Organon (LTS:0A9W) Ending Cash Position : $575 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Organon Ending Cash Position?

Organon's Ending Cash Position for the quarter that ended in Mar. 2024 was $575 Mil.

Organon's quarterly Ending Cash Position increased from Sep. 2023 ($414 Mil) to Dec. 2023 ($693 Mil) but then declined from Dec. 2023 ($693 Mil) to Mar. 2024 ($575 Mil).

Organon's annual Ending Cash Position declined from Dec. 2021 ($737 Mil) to Dec. 2022 ($706 Mil) and declined from Dec. 2022 ($706 Mil) to Dec. 2023 ($693 Mil).

Organon Ending Cash Position Historical Data

The historical data trend for Organon's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Ending Cash Position Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

319.00

12.00

737.00

706.00

693.00

Organon Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial														459.00	326.00	414.00	693.00	575.00

Organon Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Organon's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	706	+	-13
	=	693

Organon's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	693	+	-118
	=	575

Organon Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Organon's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon (LTS:0A9W) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (LTS:0A9W) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

OGN:USA OGN:Mexico 1OGN:Italy 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.

Organon (LTS:0A9W) Headlines

No Headlines